Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects
about
sameAs
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertensionThe quality of prescribing in general practice.Challenges of prescribing low-dose drug therapy for older people.Thiazide diuretics in hypertension.Anti-hypertensive medicines prescribing for medical outpatients in a premier teaching hospital in Nigeria: a probable shift of paradigm.Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemiaA randomised controlled trial for the evaluation of risk for type 2 diabetes in hypertensive patients receiving thiazide diuretics: Diuretics In the Management of Essential hypertension (DIME) study.New drug treatments for HIV infection and AIDS. A review following the Seventh International Conference on AIDS, Florence 16-21 June 1991Management of raised blood pressure in New Zealand: a discussion document.Acid-base and electrolyte abnormalities observed in patients receiving cardiovascular drugs.Prevention and treatment of the metabolic syndrome.Comparison of single and combination diuretics on glucose tolerance (PATHWAY-3): protocol for a randomised double-blind trial in patients with essential hypertension.The increase in serum uric acid concentration caused by diuretics might be beneficial in heart failure.Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.Renin: friend or foe?Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure.Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension.Meta-analysis of dose-response relationships for hydrochlorothiazide, chlorthalidone, and bendroflumethiazide on blood pressure, serum potassium, and urate.Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial.Volume-associated ambulatory blood pressure patterns in hemodialysis patients.Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide.Diuretics in clinical practice. Part II: electrolyte and acid-base disorders complicating diuretic therapy.Thiazides in the 1990s.Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.Association of Thiazide-Type Diuretics With Glycemic Changes in Hypertensive Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.Insulin resistance in systemic hypertension: pharmacotherapeutic implications.Thiazide-induced hyperglycaemia: a role for calcium-activated potassium channels?Bayesian sample sizes for exploratory clinical trials comparing multiple experimental treatments with a control.Best thiazide diuretic for hypertension.Effect of thiazide drug compound on the testicular protein and cholesterol contents of albino ratDiuretics in primary hypertension - Reloaded.Low dose thiazide diuretic. Is not available for prescribing.Salt substitutes and potassium intake.Spironolactone and chlorthalidone in uncontrolled elderly hypertensive patients treated with calcium antagonists and angiotensin II receptor-blocker: effects on endothelial function, inflammation, and oxidative stress.Low dose thiazide diuretic: Author's reply.Population Pharmacodynamic Analysis of Uric Acid-Lowering Effects of Febuxostat Based on Electronic Medical Records in Two Hospitals.Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study.Adverse effects on risk of ischaemic heart disease of adding sugar to hot beverages in hypertensives using diuretics. A six year follow-up in the Copenhagen Male Study.A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM.Relation between low dose of hydrochlorothiazide, antihypertensive effect and adverse effects.
P2860
Q24194532-D3A9DA4F-C54C-48CC-8D03-4573699BA2B6Q33572762-B4A77D09-E331-4806-8C15-E8A677C5E347Q33596150-05A4D83D-D87A-480D-8714-9E85DE8E8E5CQ33697661-6B90F21D-4797-4DBB-8779-E38541E079EFQ33911061-CD169A95-9C49-4C11-8474-D0CAA027A4C0Q33989505-C19C1386-8B7C-4D55-9B93-DD1DB32861A9Q33996330-461CE764-DE31-4C5C-87D4-932D3B7E4EBDQ34402861-69F3F08F-574F-476E-9492-9BD775A2E120Q35214317-88F2E55A-E2ED-480A-A3CE-B4F86AA990E6Q35636701-F67F2313-0F36-4249-BC67-F0871F40DF67Q35952447-404AC40C-DD32-40B5-837E-23BC934C80B7Q35963841-E758416D-BA13-448F-8835-034C6B3DD2CAQ36142224-BF0551A2-CE72-4DC2-9390-CD21699CA028Q36506245-BB43EFF0-C668-463B-805D-D58192B691E7Q36815446-1FCA89FF-B1FE-49F5-AAB7-25336EE6DA97Q36846087-E7230B06-236F-4F25-9478-3534455E2AAEQ36886618-FD028250-58BC-4EE0-8CC4-ECF04669AB14Q37059700-5FE16C43-5ABA-4A78-91F5-06C2D264AEC6Q37184569-478CDD66-88E1-48FC-80E9-2A5FEB492E30Q37350707-C4E41585-0398-44C3-836D-5907E9B3005EQ37598918-E721C893-1845-4856-81E7-D46342CEE139Q37679929-F59C4F82-67F1-494C-92F9-201C76A12057Q37949165-CCFAC013-EB85-4254-AF3C-4F67BB854135Q38444730-AD788C7A-9E0C-4C79-A9D6-FA69540C64D1Q38591219-ABBB19C5-D5A5-458F-B8A6-991999BA55A3Q40949586-8223C0C6-1E05-40BC-9F35-B64EB8216934Q41118641-486E5DA9-D574-4F64-A507-DF50529E5FC7Q41235324-1F49AA98-FAF0-4C69-B60C-FC6E4A782D36Q41892303-77B8C78E-D78A-4771-8800-54AFE4904F25Q41970729-C4446E20-5A28-49DE-B1E2-30466EAA2FABQ42380189-92208FBE-A399-4233-A81E-D3C56DCB09CEQ42591094-C6DE73D3-2A49-4608-A7EA-E92FB34E9668Q43162414-4A015E2A-EACD-4D20-A14B-3B98CD7504FFQ43249314-D4684FFC-9511-4317-8857-8180D9E0C835Q46216650-FBD8BBFA-431A-473A-8D14-303BE82EAE37Q47239976-B3A155CE-4451-47E8-A0DB-074DA2A99A52Q51562539-316BE075-919B-446E-9C62-889BED9A8412Q51582327-4D4E6661-9A70-4992-9342-D22C5D7F976EQ51587617-D0AFD9E3-2195-4CC2-83D1-EF4A45F0D5A4Q51594741-8058CE7C-D047-40E7-A7AA-70E1A9384162
P2860
Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects
description
1990 nî lūn-bûn
@nan
1990 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
name
Relation between dose of bendr ...... nd adverse biochemical effects
@ast
Relation between dose of bendr ...... nd adverse biochemical effects
@en
Relation between dose of bendr ...... nd adverse biochemical effects
@nl
type
label
Relation between dose of bendr ...... nd adverse biochemical effects
@ast
Relation between dose of bendr ...... nd adverse biochemical effects
@en
Relation between dose of bendr ...... nd adverse biochemical effects
@nl
prefLabel
Relation between dose of bendr ...... nd adverse biochemical effects
@ast
Relation between dose of bendr ...... nd adverse biochemical effects
@en
Relation between dose of bendr ...... nd adverse biochemical effects
@nl
P2093
P2860
P356
P1433
P1476
Relation between dose of bendr ...... nd adverse biochemical effects
@en
P2093
C Torp-Pedersen
J E Carlsen
P Johansen
P2860
P356
10.1136/BMJ.300.6730.975
P407
P50
P577
1990-04-14T00:00:00Z